Impact of Caregiver Beliefs on Adherence to Antipsychotic Medications in Patients With Schizophrenia

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

150 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-03-20

Study Completion Date

2019-03-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Only one third of patients with schizophrenia are observant to their treatment knowing that the lack of adherence to treatment is one of the most important predictors of relapse.

Recent work shows that the erroneous or negative beliefs of patients with schizophrenia regarding antipsychotic treatment are associated with poor compliance.

The hypothesis is that negative beliefs about the antipsychotic treatment of caregivers of patients with schizophrenia may be associated with a higher risk of poor compliance compared to caregivers with positive beliefs about treatment.

The primary purpose is to explore the correlation between caregiver beliefs about treatment and patient compliance, taking into account the level of caregiver-patient link.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Patient-Centered Medication Adherence Intervention for Schizophrenia

NCT00144027

Schizophrenia

COMPLETED NA

Adherence and Quality of Life in People With Schizophrenia and Schizoaffective Disorder

NCT01769014

Schizophrenia Schizoaffective Disorder Quality of Life

UNKNOWN

Improving Adherence to Oral Antipsychotic Medications in People With Schizophrenia

NCT00406718

Schizophrenia Schizoaffective Disorder

COMPLETED NA

Evaluation of a Psychoeducation Program for Families Caregivers of Schizophrenic Patients : Randomized Study in Two Arms

NCT03000985

Schizophrenia Mental Disorder Educational Problems +5 more

UNKNOWN NA

Relationship Between Self-compassion and Treatment Adherence in Schizophrenic Spectrum Disorders

NCT05566015

Treatment Adherence Selfcompassion Schizophrenic Spectrum Disorder

WITHDRAWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Non-interventional cross-sectional exploratory study with a single visit for patients with schizophrenia and their caregivers, who agreed to participate in the protocol.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

DSM-5 Schizophrenia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients and caregivers

Patients suffering from schizophrenia accompanied by their caregiver

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient over 18 years old
* With a diagnosis of schizophrenia according to DSM-5 criteria
* Accompanied by his main caregiver, who will be able to complete the questionnaires after having signed the information form.
* Treated with one or more antipsychotics.
* Able to complete the questionnaires related to the protocol
* Having agreed to sign the information form.

Exclusion Criteria

* Not understanding French, unable to answer questions linguistically
* Presenting an organic pathology and / or cognitive deterioration likely to hinder a good understanding of the interview
* Having already participated in the study
* presenting disorders related to the use of substances of severe intensity (such as acute intoxication, withdrawal syndrome or any state of delirium)

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No